Repligen Corp (RGEN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RGEN | ROIV | ASND | ||
| Company | Repligen Corp | Roivant Sciences Ltd | Ascendis Pharma ADR | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 139.61 | 11.65 | 123.45 | ||
| High | 142.11 | 11.97 | 124.63 | ||
| Low | 136.54 | 11.62 | 122.43 | ||
| Last | 141.76 | 11.82 | 122.64 | ||
| Change | +2.86 | +0.33 | -1.74 | ||
| % Change | +2.06% | +2.87% | -1.40% | ||
| Volume | 660,000 | 7,197,500 | 282,500 | ||
| 20-Day Average Volume | 706,255 | 4,562,355 | 472,205 | ||
| Previous Close | 138.90 | 11.49 | 124.38 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 138.55 | 11.65 | 125.90 | ||
| 20-Day Raw Stochastic | 61.41% | 72.09% | 28.83% | ||
| 20-Day Relative Strength | 51.22% | 52.84% | 42.97% | ||
| Weighted Alpha | -15.14 | +24.95 | +6.29 | ||
| Today's Opinion | 72% Sell | 72% Buy | 72% Sell | ||
| Previous Opinion | 88% Sell | 40% Buy | 100% Sell | ||
| Last Month's Opinion | 64% Sell | 64% Buy | 56% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.47% since 11/14/24 | +1.55% since 11/14/24 | -1.32% since 11/14/24 | ||
| Low | 121.52 on 11/15/24 | 11.05 on 11/18/24 | 118.05 on 11/15/24 | ||
| High | 142.11 on 11/21/24 | 11.97 on 11/21/24 | 133.00 on 11/15/24 | ||
| 1-Month | |||||
| %Chg | -4.99% since 10/21/24 | +1.72% since 10/21/24 | -4.68% since 10/21/24 | ||
| Low | 121.52 on 11/15/24 | 11.05 on 11/18/24 | 118.05 on 11/15/24 | ||
| High | 154.48 on 11/12/24 | 12.12 on 11/11/24 | 133.97 on 10/28/24 | ||
| 3-Month | |||||
| %Chg | -7.32% since 08/21/24 | +0.25% since 08/21/24 | -10.48% since 08/21/24 | ||
| Low | 121.52 on 11/15/24 | 11.05 on 11/18/24 | 111.09 on 09/12/24 | ||
| High | 154.48 on 11/12/24 | 13.06 on 09/09/24 | 155.53 on 09/20/24 | ||
| 6-Month | |||||
| %Chg | -15.06% since 05/21/24 | +5.25% since 05/21/24 | -0.17% since 05/21/24 | ||
| Low | 113.50 on 06/20/24 | 10.00 on 08/05/24 | 111.09 on 09/12/24 | ||
| High | 172.65 on 08/01/24 | 13.06 on 09/09/24 | 155.53 on 09/20/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 7,782,150 | 8,497,108 | 7,542,651 | ||
| Shares Outstanding, K | 56,027 | 739,522 | 60,642 | ||
| Annual Sales | 638,760,000 | 124,800,000 | 288,670,000 | ||
| Annual Net Income | 41,580,000 | 4,348,930,000 | -521,070,000 | ||
| Last Quarter Sales | 154,870,000 | 4,480,000 | 63,590,000 | ||
| Last Quarter Net Income | -650,000 | -230,180,000 | -109,080,000 | ||
| 60-Month Beta | 0.96 | 1.24 | 0.66 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.43 on 11/12/24 | -0.29 on 11/12/24 | -1.89 on 11/14/24 | ||
| Latest Earnings Date | 11/12/24 | 11/12/24 | 11/14/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 93.79 | 0.00 | 0.00 | ||